
Using AI to Power Custom Treatments for Rare Diseases with Steven Ringel
11.11.2025
0:00
10:18
In this episode, Steven Ringel, CEO of the Kazuna Foundation and Nome Therapeutics, joins the podcast to discuss how his team is using artificial intelligence to make personalized medicine accessible for rare disease patients. He shares emerging trends in AI and healthcare, the growing potential of individualized therapies, and his advice for passionate leaders driving innovation in the field.
Weitere Episoden von „Becker’s Healthcare Podcast“



Verpasse keine Episode von “Becker’s Healthcare Podcast” und abonniere ihn in der kostenlosen GetPodcast App.








